تحميل...
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
BACKGROUND: Neuroimaging studies have used magnetic resonance imaging-derived methods to assess brain volume loss in multiple sclerosis (MS) as a reliable measure of diffuse tissue damage. METHODS: In the CLARITY study (ClinicalTrials.gov NCT00213135), the effect of 2 years’ treatment with cladribin...
محفوظ في:
| الحاوية / القاعدة: | Mult Scler |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
SAGE Publications
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5818021/ https://ncbi.nlm.nih.gov/pubmed/28140753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517690269 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|